Profil
Aaron N.
D.
Weaver currently works at Centenara Labs AG, as Director, Interactive Strength, Inc., as Independent Director from 2022, Endogena Therapeutics, Inc., as Director, Leaf4life LLC, as Director, MagForce AG, as Member-Supervisory Board, Apeiron Investments SCA, as Head-Capital Markets from 2021, and Apeiron Partners, as Principal.
Mr. Weaver also formerly worked at Alto Neuroscience, Inc., as Director, Bionomics Ltd., as Independent Non-Executive Director from 2020 to 2024, Credit Suisse Group AG, as Head-Investment Banker from 2015 to 2017, and ATAI Life Sciences AG, as Senior General Counsel & Investor Relations Lead from 2019 to 2021.
Mr. Weaver received his undergraduate degree in 2003 from The University of Queensland, graduate degree in 2006 from Queensland University of Technology, and graduate degree from The University of Queensland.
Postes actifs de Aaron Weaver
| Sociétés | Poste | Début |
|---|---|---|
| MAGFORCE AG | Directeur/Membre du Conseil | - |
| INTERACTIVE STRENGTH INC. | Directeur/Membre du Conseil | 01/03/2022 |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops endogenous regenerative medicines | Directeur/Membre du Conseil | - |
Apeiron Investments SCA | Corporate Officer/Principal | 01/05/2019 |
Leaf4life LLC | Directeur/Membre du Conseil | - |
Apeiron Investment Group Ltd. /Private Equity/
Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Partners invests in companies located in the United States, United Kingdom and Europe. The firm focuses on a broad range of sectors and industries. It participates in seed, early and growth stage capital requirements. | Corporate Officer/Principal | 01/05/2020 |
Rejuveron Life Sciences AG
Rejuveron Life Sciences AG Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | - |
Anciens postes connus de Aaron Weaver
| Sociétés | Poste | Fin |
|---|---|---|
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Directeur/Membre du Conseil | 09/10/2024 |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Investor Relations Contact | 01/06/2021 |
| ░░░░░░ ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Aaron Weaver
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Credit Suisse Group AG
Credit Suisse Group AG Investment Banks/BrokersFinance Provides investment banking, advisory, wealth and asset management services | Finance |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Queensland University of Technology
Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MagForce AG
MagForce AG Medical SpecialtiesHealth Technology Operates as a medical technology company in the field of nanomedicine focusing on oncology | Health Technology |
Apeiron Investments SCA | |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Health Technology |
Interactive Strength, Inc.
Interactive Strength, Inc. Specialty StoresRetail Trade Sells and installs connected fitness products and related accessories & provides membership subscription services | Retail Trade |
Apeiron Investment Group Ltd. /Private Equity/
Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Partners invests in companies located in the United States, United Kingdom and Europe. The firm focuses on a broad range of sectors and industries. It participates in seed, early and growth stage capital requirements. | Finance |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops endogenous regenerative medicines | Health Technology |
Rejuveron Life Sciences AG
Rejuveron Life Sciences AG Investment ManagersFinance Functions as an alternative investment manager | Finance |
Alto Neuroscience, Inc.
Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
Leaf4life LLC |
















